(VIANEWS) - Monarch Casino & Resort (MCRI), Fresenius Medical Care AG (FMS), Trex Company (TREX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Monarch Casino & Resort (MCRI)
60.7% sales growth and 14.11% return on equity
Monarch Casino & Resort, Inc., through its subsidiaries, owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada.
Monarch Casino & Resort's sales growth this year is anticipated to be 99.3% and 12.4% for next year.
Year-on-year quarterly revenue growth grew by 544.8%, now sitting on 290.92M for the twelve trailing months.
Volume
Today's last reported volume for Monarch Casino & Resort is 55945 which is 0.54% above its average volume of 55643.
Monarch Casino & Resort's sales growth is a negative 0% for the ongoing quarter and 60.7% for the next. The company's growth estimates for the ongoing quarter and the next is 73.7% and 6.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.11%.
Volatility
Monarch Casino & Resort's last day, last week, and last month's current volatility was 3.50%, 2.04%, and 1.77%, respectively.
Monarch Casino & Resort's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.62% (day), 3.11% (last week), and 2.71% (last month), respectively.
Monarch Casino & Resort's Stock Yearly Top and Bottom Value
Monarch Casino & Resort's stock is valued at $72.48 at 16:22 EST, under its 52-week high of $76.00 and way higher than its 52-week low of $45.23.
Monarch Casino & Resort's Moving Average
Monarch Casino & Resort's worth is higher than its 50-day moving average of $68.59 and higher than its 200-day moving average of $67.40.2. Fresenius Medical Care AG (FMS)
27.6% sales growth and 9.51% return on equity
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally.
Fresenius Medical Care AG's sales growth this year is anticipated to be 19.2% and 4.6% for next year.
Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.
Volume
Today's last reported volume for Fresenius Medical Care AG is 325325 which is 13.71% below its average volume of 377040.
Fresenius Medical Care AG's sales growth for the next quarter is 27.6%. The company's growth estimates for the present quarter and the next is a negative 26% and negative -24.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.51%.
Volatility
Fresenius Medical Care AG's last day, last week, and last month's current volatility was 1.21%, 1.84%, and 1.12%, respectively.
Fresenius Medical Care AG's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.73% (day), 1.75% (last week), and 1.15% (last month), respectively.
Fresenius Medical Care AG's Stock Yearly Top and Bottom Value
Fresenius Medical Care AG's stock is valued at $35.49 at 16:22 EST, way under its 52-week high of $44.13 and above its 52-week low of $33.12.
Fresenius Medical Care AG's Moving Average
Fresenius Medical Care AG's value is higher than its 50-day moving average of $35.10 and under its 200-day moving average of $38.85.3. Trex Company (TREX)
21% sales growth and 34.12% return on equity
Trex Company, Inc. manufactures and distributes wood and plastic composite products, and related accessories primarily for residential decking, and railing applications in the United States.
Trex Company's sales growth this year is anticipated to be 31.7% and 13.3% for next year.
Year-on-year quarterly revenue growth grew by 41.2%, now sitting on 1.02B for the twelve trailing months.
Volume
Today's last reported volume for Trex Company is 850318 which is 38.53% above its average volume of 613772.
Trex Company's sales growth for the next quarter is 21%. The company's growth estimates for the present quarter and the next is 41.5% and 35.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.12%.
Volatility
Trex Company's last day, last week, and last month's current volatility was 3.88%, 1.86%, and 2.11%, respectively.
Trex Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.14% (day), 3.03% (last week), and 3.07% (last month), respectively.
Trex Company's Stock Yearly Top and Bottom Value
Trex Company's stock is valued at $113.75 at 16:22 EST, below its 52-week high of $115.90 and way above its 52-week low of $64.26.
Trex Company's Moving Average
Trex Company's worth is way higher than its 50-day moving average of $102.71 and way above its 200-day moving average of $102.80.4. Omnicell (OMCL)
19.8% sales growth and 7.91% return on equity
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
Omnicell's sales growth this year is anticipated to be 26.4% and 14.3% for next year.
Year-on-year quarterly revenue growth grew by 38.7%, now sitting on 1.07B for the twelve trailing months.
Volume
Today's last reported volume for Omnicell is 236818 which is 5% below its average volume of 249286.
Omnicell's sales growth for the next quarter is 19.8%. The company's growth estimates for the current quarter and the next is 4.4% and 6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.91%.
Volatility
Omnicell's last day, last week, and last month's current volatility was 0.01%, 0.96%, and 1.24%, respectively.
Omnicell's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.86% (day), 4.03% (last week), and 3.07% (last month), respectively.
Omnicell's Stock Yearly Top and Bottom Value
Omnicell's stock is valued at $177.32 at 16:22 EST, under its 52-week high of $182.73 and way above its 52-week low of $93.39.
Omnicell's Moving Average
Omnicell's worth is higher than its 50-day moving average of $162.23 and way higher than its 200-day moving average of $150.78.Previous days news about Omnicell(OMCL)
- Notable omnicell insider trades $960k in company stock. According to Benzinga on Wednesday, 3 November, "Dan S Johnston, EVP And Chief Legal & Admin at Omnicell (NASDAQ:OMCL), made a large buy and sell of company shares on November 2, according to a new SEC filing.", "What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Dan S Johnston exercised options to purchase 5,358 Omnicell shares for $0 on November 2. "
5. Euronet Worldwide (EEFT)
12.6% sales growth and 8.35% return on equity
Euronet Worldwide, Inc. provides payment and transaction processing and distribution solutions to financial institutions, agents, retailers, merchants, content providers, and individual consumers worldwide.
Euronet Worldwide's sales growth this year is anticipated to be 19% and 18.2% for next year.
Year-on-year quarterly revenue growth grew by 35.4%, now sitting on 2.74B for the twelve trailing months.
Volume
Today's last reported volume for Euronet Worldwide is 1468480 which is 331.35% above its average volume of 340432.
Euronet Worldwide's sales growth for the next quarter is 12.6%. The company's growth estimates for the current quarter and the next is 25% and 29.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.35%.
Volatility
Euronet Worldwide's last day, last week, and last month's current volatility was 5.99%, 2.96%, and 2.37%, respectively.
Euronet Worldwide's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.26% (day), 4.85% (last week), and 3.84% (last month), respectively.
Euronet Worldwide's Stock Yearly Top and Bottom Value
Euronet Worldwide's stock is valued at $118.75 at 16:22 EST, way below its 52-week high of $167.71 and way above its 52-week low of $95.67.
Euronet Worldwide's Moving Average
Euronet Worldwide's value is below its 50-day moving average of $125.86 and way below its 200-day moving average of $136.14.6. Movado Group (MOV)
9.9% sales growth and 18.28% return on equity
Movado Group, Inc. designs, develops, sources, markets, and distributes watches in the United States and internationally.
Movado Group's sales growth this year is anticipated to be 41.4% and 8% for next year.
Year-on-year quarterly revenue growth grew by 96.4%, now sitting on 656.87M for the twelve trailing months.
Volume
Today's last reported volume for Movado Group is 73823 which is 42.75% below its average volume of 128960.
Movado Group's sales growth is a negative 0% for the ongoing quarter and 9.9% for the next. The company's growth estimates for the ongoing quarter and the next is 44.3% and negative -19%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.28%.
Volatility
Movado Group's last day, last week, and last month's current volatility was 4.09%, 2.29%, and 2.14%, respectively.
Movado Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.01% (day), 3.61% (last week), and 3.43% (last month), respectively.
Movado Group's Stock Yearly Top and Bottom Value
Movado Group's stock is valued at $35.34 at 16:22 EST, under its 52-week high of $38.15 and way above its 52-week low of $11.29.